Volume 3, 2009 - Online Edition | In This Issue
Ten Extraordinary Years of Growth and Discovery >
Building on Our Advances in Genome Science >
Paving the Future with Cutting Edge Research >
Message from the President >
Where There is a WILL ... There is a Way to End Lupus >
The Face of Lupus: Fighting the Disease on Many Fronts >
Double the Impact of Your Generosity >
Supporting Our Lupus Research Update >
Shoe News: A Doctor Who is Also a Lupus Patient >
It's time to put on your Walking Shoes >
Federal Employees Make a Real Difference >
Supporting Our Lupus Research Update
The ALR is pleased to announce that the pharmaceutical company UCB will provide support for upcoming issues of our newsletter, Lupus Research Update.
UCB has recently released promising results of the early phase of their trial that tested epratuzumab — their potential new lupus drug. The ALR is excited by all advancement in the treatment of lupus and we will continue to closely monitor UCB's work. Be sure to look for our updates on this hopeful news.
To everyone at UCB, we extend our warm gratitude.